key: cord-0721662-1vc5ntlj
authors: Korevaar, Daniël A.; Kootte, Ruud S.; Smits, Loek P.; van den Aardweg, Joost G.; Bonta, Peter I.; Schinkel, Janke; Vigeveno, René M.; van den Berk, Inge A.H.; Scheerder, Maeke J.; Lemkes, Bregtje A.; Goorhuis, Abraham; Beenen, Ludo F.M.; Annema, Jouke T.
title: Added value of chest CT in suspected COVID-19: an analysis of 239 patients
date: 2020-07-16
journal: Eur Respir J
DOI: 10.1183/13993003.01377-2020
sha: 11177f96099fb632cb58e564e546d891a18fd80a
doc_id: 721662
cord_uid: 1vc5ntlj

“In a high-prevalence emergency department setting, chest CT showed a high probability of COVID-19 in 30% of patients with a negative or indeterminate initial RT-PCR result”

Since the outbreak of the COVID-19 (coronavirus disease 2019) pandemic, clinicians have been struggling with the optimal diagnostic approach of suspected patients. RT-PCR (real-time reverse transcriptase-polymerase chain reaction) testing of respiratory samples is generally being considered as the reference standard for establishing SARS-CoV-2 infection.

[1] However, RT-PCR results take hours to become available and, although highly specific, sensitivity is moderate. [2] [3] [4] This could result in delayed and suboptimal clinical decision making.

Several reports have suggested a potential role for chest CT (computed tomography) in patients with suspected COVID-19. [5] [6] [7] [8] [9] [10] Major advantages of CT are that it provides immediate results and can identify alternative diagnoses for respiratory symptoms. CT may show signs suspicious or typical of COVID-19 in patients with a negative RT-PCR result, ensuring that the patient remains isolated. On the other hand, a negative CT result in combination with a negative RT-PCR result may exclude COVID-19 with a higher level of certainty, in which case patient de-isolation can be considered, and additional diagnostic work-up can be initiated. In this study, we evaluated the added value of chest CT over RT-PCR testing alone.

Consecutive patients with suspected COVID-19 who presented to the emergency department of our university hospital (Academic Medical Center, Amsterdam University Medical Centers, the Netherlands) from March 16 th to April 16 th were retrospectively assessed for inclusion. Patients with suspected COVID-19 were those with (1) fever, (2) cough or dyspnea, or (3) other signs suggestive of COVID-19 (e.g. gastro-intestinal symptoms).

Patients were included if they were 18 years or older, required hospital admission, and underwent both chest CT and RT-PCR testing for SARS-CoV-2 infection upon admission. In our hospital, performing both these tests is standard practice for patients with suspected COVID-19 requiring admission. We excluded patients who already had a prior positive RT-PCR result. Data were extracted from patient records by one author (DAK, RSK or LPS).

A non-enhanced low-dose chest CT scan was obtained from all patients (Somatom Force, Siemens Healthineers, Forchheim, Germany). CT images were read as part of standard clinical practice by attending radiologists, with varying degrees of experience. To improve uniformity, an informal second read was performed in some cases by a dedicated acute radiologist, and disagreements were solved by consensus. The radiological probability of pulmonary manifestations of COVID-19 was reported based on the 'CO-RADS classification', a standardized reporting system for patients with suspected COVID-19, ranging from 1 (very unlikely) to 5 (very likely). [11, 12] In this study, CO-RADS scores of 1-2 were considered as negative, scores of 4-5 were positive, and a score of 3 was indeterminate. CT readers were not blinded to clinical information, but RT-PCR results were never available at the time of reading. If CT reports did not contain a CO-RADS score (n=20), images were re-read by a radiologist blinded to the RT-PCR results (LFB).

Nose and throat swabs, and, if possible, sputum samples, were obtained for RT-PCR testing of SARS-CoV-2 infection. [13] When the initial RT-PCR result was negative or indeterminate, but clinical suspicion of COVID-19 remained, repeat RT-PCR testing was generally performed, most often within the first 24 hours after admission. In this study, patients with a positive initial or repeat RT-PCR result within 7 days after admission were considered to have COVID-19, whereas patients who only had negative RT-PCR results and a CO-RADS score of 1-3 were considered not to have COVID-19. For patients who had negative RT-PCR results but a CO-RADS score of 4-5, serological testing for SARS-CoV-2 antibodies was performed if serum was available (Biozek, COVID-19 IgG/IgM rapid test), and the final diagnosis was considered as 'COVID-19 very likely' if this was positive. If no serum was available or serology was negative, all the available clinical information (including additional microbiological tests) was assessed in a multidisciplinary meeting including two pulmonologists (PIB, JTA), an infectiologist (AG), a virologist (JCS) and a radiologist (LFB), to reach consensus about the final diagnosis, classified as 'COVID-19 very likely', 'uncertain, or 'COVID-19 very unlikely'. This meeting was held 7 days after admission of the last patient in the study. The retrospective nature of our study may be considered a limitation, but risk of selection bias is limited as only 4.4% of patients admitted with suspected COVID-19 were excluded because CT or RT-PCR testing was not performed. Although CT scans were scored by single readers with varying levels of experience, this reflects daily clinical practice. As there is currently no reliable reference standard for COVID-19, we had to rely on ruling-out other explanations and multidisciplinary consensus in patients with negative RT-PCR results, which may have led to false positive CT results. Compared to our study, a much larger proportion of false-positive CT results against RT-PCR testing was identified by Ai and colleagues in their analysis of 1014 patients with suspected COVID-19, resulting in a specificity of only 25%. [7] This difference may be explained by the fact that we strictly applied a standardized reporting system (CO-RADS), and because their study was performed in the early phase of the pandemic; clinical knowledge on typical radiological findings in COVID-19 has increased tremendously since then and could be applied by radiologists in our hospital. [14] In conclusion, in a high-prevalence emergency department setting, we found that chest CT showed high probability of COVID-19 (CO-RADS 4-5) in 29.9% of patients with a negative or indeterminate initial RT-PCR result. As the majority of these patients (81.6%) had a proven or 'very likely' diagnosis of COVID-19 after repeat RT-PCR testing or clinical follow-up, we believe that CT helps in the identification of patients who should be admitted in isolation. CT showing low or intermediate probability of COVID-19 combined with a negative RT-PCR rarely resulted in a positive subsequent RT-PCR result and de-isolation in such patients may be considered. Based on these findings, we recommend the use of chest CT in combination with RT-PCR testing in patients with suspected COVID-19 in emergency departments, provided that adequate infection control protocols in CT suites are in place. Whether this strategy is superior to one that incorporates chest Xray in terms of accuracy, patient-important outcomes or costs is currently unknown and could be subject to future studies. 

Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review

Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?

Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Clinical and CT features of early stage patients with COVID-19: a retrospective analysis of imported cases in Shanghai, China

High-resolution computed tomography features of 17 cases of coronavirus disease 2019 in Sichuan province, China

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic: A Multinational Consensus Statement From the Fleischner Society

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China

Imaging tests for the diagnosis of COVID-19 (protocol). The Cochrane database of systematic reviews

CO-RADS -A categorical CT assessment scheme for patients with suspected COVID-19: definition and evaluation

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients